- Home
- EDD vs TKNO Comparison
EDD vs TKNO Comparison
Compare EDD & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDD
- TKNO
- Stock Information
- Founded
- EDD 2007
- TKNO 1996
- Country
- EDD United States
- TKNO United States
- Employees
- EDD N/A
- TKNO N/A
- Industry
- EDD Finance Companies
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- EDD Finance
- TKNO Health Care
- Exchange
- EDD Nasdaq
- TKNO Nasdaq
- Market Cap
- EDD 329.4M
- TKNO 256.9M
- IPO Year
- EDD N/A
- TKNO 2021
- Fundamental
- Price
- EDD $5.30
- TKNO $4.35
- Analyst Decision
- EDD
- TKNO
- Analyst Count
- EDD 0
- TKNO 0
- Target Price
- EDD N/A
- TKNO N/A
- AVG Volume (30 Days)
- EDD 254.3K
- TKNO 224.0K
- Earning Date
- EDD 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- EDD 7.52%
- TKNO N/A
- EPS Growth
- EDD N/A
- TKNO N/A
- EPS
- EDD N/A
- TKNO N/A
- Revenue
- EDD N/A
- TKNO $38,923,000.00
- Revenue This Year
- EDD N/A
- TKNO $9.52
- Revenue Next Year
- EDD N/A
- TKNO $15.20
- P/E Ratio
- EDD N/A
- TKNO N/A
- Revenue Growth
- EDD N/A
- TKNO 11.40
- 52 Week Low
- EDD $4.22
- TKNO $4.00
- 52 Week High
- EDD $4.95
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- EDD 56.10
- TKNO 43.35
- Support Level
- EDD $5.24
- TKNO $4.22
- Resistance Level
- EDD $5.42
- TKNO $4.94
- Average True Range (ATR)
- EDD 0.05
- TKNO 0.29
- MACD
- EDD -0.01
- TKNO -0.00
- Stochastic Oscillator
- EDD 40.00
- TKNO 16.75
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.